Vulvitis: Clinical Trials

4 trials for Vulvitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Unknown 4
Phase 21Unknown 1

Follow Vulvitis: new trials by email Literature Review of Vulvitis trials Research Report on Vulvitis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Recurrent Vulvovaginal Candidiasis
SHR8008, Fluconazole - Recurrent Vulvovaginal Candidiasis
Phase 3UnknownJiangsu HengRui Medicine Co., Ltd.1962021-09-142021-10-12
A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)
Prof-001, Fluconazole 150 mg, Placebo cream - Recurrent Vulvovaginal Candidiasis
Phase 2 / Phase 3UnknownProFem GmbH4322019-10-012022-09-22
Ketoconazole Gel Versus Terconazole Cream for Vaginal Candidiasis
Ketoconazole, Terconazole - Vaginal Candidiasis
Phase 3UnknownAssiut University692018-04-012018-03-22
Dysbiosis in Localized Provoked Vulvodynia (LPV)
Low Oxalate Diet - Vulvodynia, Vulvar Vestibulitis
Phase 3UnknownWestern Galilee Hospital-Nahariya702015-03-012015-03-20

Narrower conditions

Candidiasis, Vulvovaginal (3)  ·  Vulvar Vestibulitis (1)  ·  Vulvodynia (1)  ·  Vulvovaginitis (1)

Broader conditions

Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genital Diseases (4)  ·  Genital Diseases, Female (4)  ·  Urogenital Diseases (4)  ·  Vulvar Diseases (4)  ·  Bacterial Infections and Mycoses (3)  ·  Candidiasis (3)  ·  Infections (3)  ·  Mycoses (3)  ·  Vaginal Diseases (3)  ·  Vaginitis (3)  ·  Vulvovaginitis (2)

Interventions

Fluconazole (2)  ·  Ketoconazole (1)  ·  terconazole (1)

Sponsors

Assiut University (1)  ·  Jiangsu HengRui Medicine Co., Ltd. (1)  ·  ProFem GmbH (1)  ·  Western Galilee Hospital-Nahariya (1)

Countries

Austria (1)  ·  China (1)  ·  Poland (1)  ·  Slovakia (1)

Top investigators

Herbert Kiss, Prof. (1)  ·  Jacob Bornstein, MD (1)

Results publications

PMID 35943448, PMID 41845293